Myonexus Therapeutics receives FDA orphan drug designation for LGMD type 2E treatment
Credit: None (COLUMBUS, OH-- April 23, 2018 10:00 am EDT) Myonexus Therapeutics, a clinical-stage gene therapy company developing first ever corrective gene therapies for limb...